New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
On December 17, 2021, TWi Pharmaceuticals launched an authorized brand alternative of Takeda’s Dexilant (dexlansoprazole) delayed-release capsules.
Download PDF
Return to publications
